Compounds > pirfenidone
Page last updated: 2024-08-23

pirfenidone and Lymphangiomyomatosis

pirfenidone has been researched along with Lymphangiomyomatosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belloli, EA; Flaherty, KR; Martinez, FJ1
Günther, A; Markart, P; von der Beck, D1

Reviews

2 review(s) available for pirfenidone and Lymphangiomyomatosis

ArticleYear
Update in Interstitial Lung Disease 2014.
    American journal of respiratory and critical care medicine, 2015, Sep-01, Volume: 192, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Doxycycline; Enzyme Inhibitors; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Lymphangioleiomyomatosis; Pyridones; Sarcoidosis, Pulmonary; Sirolimus; Smoking; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha

2015
[Interstitial lung disease].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Guidelines as Topic; Humans; Lung Diseases, Interstitial; Lymphangioleiomyomatosis; Pyridones; Sarcoidosis; Scleroderma, Systemic

2011